876300-82-2

Upstream product

• 1377269-45-8 N'-(5-bromopyridin-2-yl)-2-methoxybenzohydrazide 
• 77992-44-0 5-bromo-2-hydrazinylpyridine 
• 53939-30-3 5-bromo-2-chloropyridine 

Downstream Products

• 1377268-74-0 3-(2-methoxyphenyl)-6-(4-methylphenyl)-[1,2,4]triazolo[4,3-a]pyridine 
• 1377268-53-5 3-(2-methoxyphenyl)-6-(4-methoxyphenyl)-[1,2,4]triazolo[4,3-a]pyridine 
• 1377268-94-4 6-(4-methoxy-3-nitrophenyl)-3-(2-methoxy-5-nitrophenyl)-[1,2,4]triazolo[4,3-a]pyridine 

Relevant academic research and scientific papers

3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF

Disclosed are 3-aryl-6-aryl-[1,2,4]triazolo[4,3-a]pyridines thereof, represented by the Formula (I) wherein Ar1, Ar2, R1-R3 are defined herein. Compounds having Formula (I) are inhibitors of cell proliferation.

3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF

Disclosed are 3-aryl-6-aryl-[1,2,4]triazolo[4,3-a]pyridines thereof, represented by the Formula (I) wherein Ar1, Ar2, R1-R3 are defined herein. Compounds having Formula (I) are inhibitors of cell proliferation.

Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors

A compound of formula (I), or a pharmaceutically acceptable salt and/or solvate (including hydrate) thereof; and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease.